Viatris | VTRS - Net Income

Stock Price
13.73
Daily Change
-0.07 -0.51%
Monthly
-14.08%
Yearly
45.75%
Q1 Forecast
13.10

Viatris reported $-340.1M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Pharma Mar EUR 59.66M 63.76M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025